Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive said, as tensions simmer between Copenhagen and Washington.
As expected, the tariffs were announced, 25% from Mexico and Canada, and 10% from China ... Cramer mentioned that he expects Novo Nordisk A/S (NYSE:NVO) to forecast a good 2025 like its peer, Eli ...
2don MSN
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results